Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 304 participants.

Also called NCT01669382

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 304 participants (enrolled count) (from the registry)
Sponsor
University Hospital Erlangen (from the registry)
Registry
  • NCT NCT01669382
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01669382. Randomized; single masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites
Condition
Acute Coronary Syndromes
Condition
Stable Angina Pectoris
Lead sponsor
University Hospital Erlangen (class: other)

Record details

Record id
cardio:ct-nct01669382
Content hash
0ab676913ac735b69350ac7e91a9555d36c8a88ba05f1ab8262404ddb3524da5